Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Yu-Chun Song"'
Autor:
Yu-Chun Song, Zhi-Hui Hu, Xue-Na Yan, Hui Fang, Yu Tang, Hao Jing, Kuo Men, Na Zhang, Jun Zhang, Jing Jin, Qiu-Zi Zhong, Jun Ma, Wei-Fang Yang, Ya-Hua Zhong, Li-Hua Dong, Xiao-Hong Wang, Hong-Fen Wu, Xiang-Hui Du, Xiao-Rong Hou, Jian Tie, Yu-Fei Lu, Li-Na Zhao, Ye-Xiong Li, Shu-Lian Wang
Publikováno v:
Radiation Oncology, Vol 18, Iss 1, Pp 1-12 (2023)
Abstract Purpose To report the planning benchmark case results of the POTENTIAL trial—a multicenter, randomized, phase 3 trial—to evaluate the value of internal mammary nodal (IMN) irradiation for patients with high-risk breast cancer. Methods Al
Externí odkaz:
https://doaj.org/article/c23db8d9474f440dbad96c087b738953
Autor:
Yu-Chun Song, Zhou Huang, Hui Fang, Yu Tang, Hao Jing, Yong-Wen Song, Jing Jin, Yue-Ping Liu, Bo Chen, Yuan Tang, Shu-Nan Qi, Ning-Ning Lu, Ning Li, Ye-Xiong Li, Shu-Lian Wang
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundTo compare recurrence and survival outcomes between breast-conserving surgery (BCS) and mastectomy after neoadjuvant chemotherapy (NACT).MethodsThe data of 730 patients who underwent NACT between 2000 and 2014 were retrospectively reviewed.
Externí odkaz:
https://doaj.org/article/94d7b2fadde54cf5b557e241ad71410f
Autor:
Yu-Chun Song, Guang-Yi Sun, Hui Fang, Yu Tang, Yong-Wen Song, Chen Hu, Shu-Nan Qi, Bo Chen, Hao Jing, Yuan Tang, Jing Jin, Yue-Ping Liu, Ning-ning Lu, Ye-Xiong Li, Shu-Lian Wang
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
PurposeTo report patients’ quality of life (QoL) at 1 year in a phase 2 randomized trial comparing partial breast irradiation (PBI) with whole-breast irradiation (WBI) after breast-conserving surgery (BCS) for breast cancer.MethodsWomen aged ≥ 45
Externí odkaz:
https://doaj.org/article/a1b19802259c407d8c814462fbce4e67
Autor:
Guang-Yi Sun, Hao Jing, Shu-Lian Wang, Yong-Wen Song, Jing Jin, Hui Fang, Yue-Ping Liu, Hua Ren, Yu Tang, Xu-Ran Zhao, Yu-Chun Song, Si-Ye Chen, Zhuan-Bo Yang, Bo Chen, Yuan Tang, Ning Li, Ning-Ning Lu, Shu-Nan Qi, Yong Yang, Ye-Xiong Li
Publikováno v:
Frontiers in Oncology, Vol 10 (2021)
Background and PurposeWe investigated the locoregional effect of trastuzumab, and determined whether patients with human epidermal growth factor receptor (HER)2-positive breast cancer (BC) treated with trastuzumab could achieve comparable efficacy to
Externí odkaz:
https://doaj.org/article/e711d5afb38747a6bab8af6bf0f09974
Autor:
Si-Ye Chen, Guang-Yi Sun, Yu Tang, Hao Jing, Yong-Wen Song, Jing Jin, Yue-Ping Liu, Xu-Ran Zhao, Yu-Chun Song, Bo Chen, Shu-Nan Qi, Yuan Tang, Ning-Ning Lu, Ning Li, Hui Fang, Ye-Xiong Li, Shu-Lian Wang
Publikováno v:
European Journal of Cancer. 174:153-164
To investigate the appropriate timing of radiotherapy (RT) after mastectomy and adjuvant chemotherapy for women with high-risk breast cancer.Post hoc analyses of 584 patients with stage II and III breast cancer from a randomised controlled clinical t
Autor:
Yu-Chun Song, Xue-Na Yan, Yu Tang, Hao Jing, Na Zhang, Jun Zhang, Ya-Hua Zhong, Li-Hua Dong, Hong-Fen Wu, Jian Tie, Qiu-Zi Zhong, Wei-Fang Yang, Xiao-Hong Wang, Xiao-Rong Hou, Yu-Fei Lu, Li-Na Zhao, Jing Jin, Ye-Xiong Li, Shu-Lian Wang
Publikováno v:
Practical Radiation Oncology. 12:397-408
To estimate the variations in clinical target volumes (CTVs) and organs at risk delineation within the quality assurance (QA) program of the POTENTIAL trial, which is a multicenter, randomized phase 3 trial evaluating postmastectomy radiation therapy
Autor:
Yu-Chun Song, Jie Kong, Na Li, Xiao-Lei Liu, Xiao-Hong Li, Long-Yu Zhu, Yu-Wei Wang, Hui Fang, Hao Jing, Yu Tang, Ye-Xiong Li, Xiao-Hong Wang, Jun Zhang, Shu-Lian Wang
Publikováno v:
Radiotherapy and Oncology. 183:109639
Autor:
Yong Wen Song, Bo Chen, Ye Xiong Li, Hao Jing, Yuan Tang, Yu Chun Song, Shu Nan Qi, Jing Jin, Yu Tang, Shu Lian Wang, Hui Fang, Ning Ning Lu, Chen Hu, Yue Ping Liu, Guangyi Sun
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
PurposeTo report patients’ quality of life (QoL) at 1 year in a phase 2 randomized trial comparing partial breast irradiation (PBI) with whole-breast irradiation (WBI) after breast-conserving surgery (BCS) for breast cancer.MethodsWomen aged ≥ 45
Autor:
Guang-Yi, Sun, Hao, Jing, Shu-Lian, Wang, Yong-Wen, Song, Jing, Jin, Hui, Fang, Yue-Ping, Liu, Hua, Ren, Yu, Tang, Xu-Ran, Zhao, Yu-Chun, Song, Si-Ye, Chen, Zhuan-Bo, Yang, Bo, Chen, Yuan, Tang, Ning, Li, Ning-Ning, Lu, Shu-Nan, Qi, Yong, Yang, Ye-Xiong, Li
Publikováno v:
Frontiers in Oncology
Background and Purpose We investigated the locoregional effect of trastuzumab, and determined whether patients with human epidermal growth factor receptor (HER)2-positive breast cancer (BC) treated with trastuzumab could achieve comparable efficacy t
Autor:
Wei-Ming Chen, Michael W.Y. Chan, Chuang-Ming Wang, Chia-Bin Chang, Shu-Fen Wu, Shiao-Pieng Lee, Yu-Chun Song
Publikováno v:
Journal of Autoimmunity. 107:102362
Dendritic cells (DCs) play key roles in regulating T cell proliferation and differentiation, and epigenetic modification involves in this process. In the periphery, programmed death ligand-1 (PD-L1) expressed on antigen-presenting cells interacts wit